{
  "ticker": "JNJ",
  "target_date": "2025-07-18",
  "actual_date": "2025-07-18",
  "collected_at": "2025-12-08T12:01:56.958845",
  "price": {
    "open": 161.71,
    "high": 162.86,
    "low": 161.15,
    "close": 161.4818878173828,
    "volume": 9792600,
    "change_1d_pct": 0.44,
    "change_7d_pct": 4.75,
    "change_30d_pct": 6.84
  },
  "technicals": {
    "rsi_14": 75.51,
    "sma_20": 153.67,
    "sma_50": 152.03,
    "macd": 2.155,
    "macd_signal": 1.214,
    "macd_histogram": 0.941,
    "bb_upper": 161.74,
    "bb_lower": 145.6,
    "price_vs_sma20_pct": 5.08,
    "price_vs_sma50_pct": 6.22,
    "volume_ratio": 1.05
  },
  "fundamentals": {
    "market_cap": 489267593216,
    "pe_ratio": 19.601835,
    "forward_pe": 19.158018,
    "price_to_book": 6.163687,
    "price_to_sales": 5.309527,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.28,
    "pct_from_52w_low": 44.35
  },
  "macro": {
    "spy": {
      "price": 625.84,
      "change_1d_pct": -0.07,
      "change_7d_pct": 0.28
    },
    "vix": {
      "level": 16.41,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.43
    },
    "dollar_index": {
      "level": 98.48
    },
    "gold": {
      "price": 3353.0
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Earnings live: Second quarter earnings season off to strong start with Tesla, Google on deck",
      "source": "Yahoo",
      "datetime": 1752870295,
      "summary": "Second quarter earnings season kicked off to a strong start. Investors now look ahead to Tesla and Google reporting the first \"Magnificent Seven\" results next week.",
      "url": "https://finnhub.io/api/news?id=9dd115c039f0e58de3525c13dc82f04a6a6151b63c3dce07c052b2ed9d2e95cc"
    },
    {
      "headline": "J&J Expects Oncology Sales of USD 50B by 2030: Can It Achieve the Goal?",
      "source": "Yahoo",
      "datetime": 1752851220,
      "summary": "JNJ eyes $50B in oncology sales by 2030, driven by drugs like Darzalex, Erleada, new launches including Carvykti and Tecvayli, and its cancer pipeline.",
      "url": "https://finnhub.io/api/news?id=d2a9086031965b4ec27f20fd36ef39587dbf3fb10ab06cf42c7000555d686142"
    },
    {
      "headline": "FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo",
      "source": "Yahoo",
      "datetime": 1752849540,
      "summary": "GSK stock falls as an FDA panel votes against its Blenrep combo, casting doubt on U.S. approval hopes.",
      "url": "https://finnhub.io/api/news?id=f9d4168f748aefdc8492dc42407a85fcc281ce8bf6ade7ebc585573445d8811a"
    },
    {
      "headline": "Johnson & Johnson price target raised to $167 from $164 at Guggenheim",
      "source": "Yahoo",
      "datetime": 1752840945,
      "summary": "Guggenheim raised the firm\u2019s price target on Johnson & Johnson to $167 from $164 and keeps a Neutral rating on the shares after the company delivered a \u201cstrong\u201d Q2 and gave an \u201cencouraging outlook\u201d for the company\u2019s growth prospects in the second half. The firm keeps a Neutral rating on J&J shares a",
      "url": "https://finnhub.io/api/news?id=abb41754f645c563d1b5260245f72ec01b3a11bf5b59b3027512b35835ae3a6a"
    },
    {
      "headline": "Wall Street Roundup: Crypto Clarity, Financial Earnings, JNJ And JOBY",
      "source": "SeekingAlpha",
      "datetime": 1752840300,
      "summary": "Crypto legislation back on track, Bitcoin hitting highs. Financial earnings holding ground.",
      "url": "https://finnhub.io/api/news?id=f57bdc1e3315b783f4b721140fcc67f405786cd4e62db71efbf32f1b23a6b71d"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-07-18",
      "description": "xslF345X05/wk-form4_1752869553.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/xslF345X05/wk-form4_1752869553.xml"
    },
    {
      "form": "8-K",
      "date": "2025-07-16",
      "description": "jnj-20250716.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000170/jnj-20250716.htm"
    },
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760336.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000156/xslF345X05/wk-form4_1749760336.xml"
    },
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760229.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000154/xslF345X05/wk-form4_1749760229.xml"
    },
    {
      "form": "8-K",
      "date": "2025-06-10",
      "description": "jnj-20250610.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000152/jnj-20250610.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}